Advertisement
MaryRose Reaston is the Founder of Emerge Diagnostics, an Oklahoma-based company created to commercialize the Electrodiagnostic Functional Assessment (EFA). The EFA is a medical evaluation that uses a propriatry FDA cleared and registered 510K Class-II medical device designed to assess, evaluate, and monitor musculoskeletal injuries. Emerge Diagnostics focuses on reducing their clients’ claims costs via early resolution and enhanced treatment options for soft tissue injuries. They are experts in the field of electrodiagnostic medicine as it applies to injuries in the workplace and leaders in the ongoing development of innovative technology.
She has been instrumental in the development, commercialization, marketing and governmental acceptance of electrodiagnostic testing and has been classified in Federal Court as an expert witness in the area of electrodiagnostic techniques and evaluations. She has published articles on EFA in The Journal of Occupational Medicine and Technology, IEEE, is the holder of several patents on the technology and methods and recently won the 2012 Risk Innovator of the Year and the Liberty Mutual Responsibility Leader award from Risk & Insurance Magazine for the EFA-STM program. She has testified before OSHA and Congress on the EFA
RECENT ARTICLES BY MaryRose Reaston

Baseline Testing: Book End Solution - Does It Qualify as Business Necessity?
Given all the legal mandates for the ADA and EEOC, coupled with state workers' compensation laws and Federal Mandatory reporting issues for work-related injuries, why do post-offer pre-placement tests? A better solution is baseline testing or a book end solution.

The Healthcare Industry Is Ripe For Baseline Testing
The only way the Healthcare industry can manage their musculoskeletal disorder cases is by adopting the the EFA-STM baseline test, which is an objective, evidence-based tool designed to measure the functional status of an injured worker and to identify return-to-work opportunities. We are pleased to include a phone interview with Dr. Reaston with this article through a special media partnership with WRIN.tv.

What An Employer Can Do To Reduce Soft Tissue Injuries In The Transportation Industry
Employers need a way to manage their Musculoskeletal Disorder exposure and provide better care to their injured workers. The key to managing this problem is for employers to obtain the ability to only accept claims that arise out of the course and scope of employment.

Workers’ Compensation In California: No Longer Just Permanent And Stationary
The workers' compensation landscape in California is changing, and employers need to be prepared for what lies ahead.

Don’t Get Washed Away By The Medicare Set-Aside
One scenario is that when CMS/Medicare learns (and they will) it has been paying for work comp-related medical care, it will seek repayment from the claimant. The claimant, having spent the work comp settlement, will be unable to pay. Ultimately, it will be the employer and/or insurance carrier that will be held accountable.
Insurance Thought Leadership exists to "simplify the complex." The insurance industry is fraught with complexity so our defining vision is to aggregate and deliver best practice solutions from highly respected experts in their field. Insurance Thought Leadership provides knowledge and experience at a time when its needed most, times of sweeping change and market uncertainty.
Whether it's Healthcare, Worker's Compensation, Property & Casualty, Auto, Sophisticated Life Insurance designs, Directors & Officer's, Safety, Risk Control or other Claims Management, Insurance Thought Leadership promises to deliver the most relevant mind share the industry has to offer, thus our defining vision … to "simplify the complex."